COVID-19 updates, including vaccine information, for our patients and visitors Learn More

Menu
Search

Director of New UCSD Clinical Research Protections Program Appointed

 

November 07, 2005  |  

Michael P. Caligiuri, Ph.D., UCSD Professor of Psychiatry, has been named the first Director of the Clinical Research Protections (CRESP) Program at the University of California, San Diego (UCSD) Health Sciences, effective January 3, 2006.

The appointment was announced by Judith L. Swain, M.D., Director of UCSD’s College of Integrated Life Sciences and Dean for Translational Medicine and David N. Bailey, M.D., Deputy Vice Chancellor for Health Sciences and Dean, Faculty & Student Matters.

“We are fortunate to have attracted someone of Dr. Caligiuri’s caliber to this significant new position, and I look forward to working with him to make this program a national model,” said Swain.

CRESP is a new program that includes both the Human Research Protections Program, formerly headed by Daniel Masys, M.D., and the Research Compliance Office, formerly directed by Charles Mittman, M.D. The newly position has been created to provide better coordination of the activities of these two closely related programs and will further enhance the protection of people who participate in clinical research trials for new drug therapies and treatments.

Caligiuri is a nationally renowned researcher in neuro-psychiatric movement disorders.

He came to UCSD as a post-doctoral fellow in 1986 after earning his Ph.D. degree from the University of Wisconsin and joined the Division of Geriatric Psychology in 1988. A member of the UC San Diego Institutional Review Board (IRB) since 1997, Caligiuri has served as an IRB Vice Chair since 2004. He is a member the Society for Neuroscience, the International Organization for Brain Research, and the Society of Biological Psychiatry, among other professional organizations, and has published numerous original articles in the field of neuromuscular disorders related to psychiatric disturbances and psychopharmacologic mechanisms.

 

“Dr. Caligiuri has both the ability and the vision to ensure that UC San Diego Health Sciences continues on the path of excellence established by Dr. Masys.” said Bailey. “By combining research compliance and institutional review board functions under one individual, UCSD underscores its commitment to the highest scientific and ethical standards in clinical research.”

#  #  #

 

News Media Contact: Debra Kain, 619-543-6163, ddkain@ucsd.edu

Note to broadcast and cable producers: UCSD provides an on-campus satellite uplink facility for live or pre-recorded television interviews.  Please phone, or e-mail, the media contact listed above to arrange an interview.

UCSD Health Sciences Communications HealthBeat: /news/




Media Contact

Share This Article


Related News

9/10/2021
UC San Diego School of Medicine receives $6.1M to launch a new research center studying the effects of maternal antibiotic use on breast milk and infant health. The center is funded by National Instit ...
9/9/2021
UC San Diego School of Medicine researchers will receive $6.4 million in National Institutes of Health grant funding to study how external signals and genetic variations influence the behavior of one ...
9/8/2021
Researchers found that breastfeeding mothers who received either the Pfizer-BioNTech or Moderna vaccination reported the same local or systemic symptoms as what has been previously reported in non-bre ...
9/7/2021
UC San Diego Health improved care for more than 32,000 Medicare beneficiaries in San Diego, Riverside, and Imperial Counties, and saved Medicare close to $7 million by utilizing population health tech ...



Follow Us